Lord, Abbett & Co. LLC Dynavax Technologies Corp Transaction History

Lord, Abbett & Co. LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$11.85 - $16.0 $4.3 Million - $5.81 Million	-362,826 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$15.15 - $20.75 $1.13 Million - $1.55 Million	74,908 Added 26.02%	362,826 $5.53 Million
Q1 2018 May 15, 2018	SELL	$14.65 - $19.9 $3.36 Million - $4.56 Million	-229,232 Reduced 44.33%	287,918 $5.72 Million
Q4 2017 Feb 14, 2018	SELL	$17.3 - $24.08 $4.05 Million - $5.64 Million	-234,051 Reduced 31.16%	517,150 $9.67 Million
Q3 2017 Nov 14, 2017	SELL	$15.2 - $21.5 $831,728 - $1.18 Million	-54,719 Reduced 6.79%	751,201 $16.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	805,920	805,920 $7.78 Million

257

132M

371K

99.2K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.44B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.